These data indicated that the treatment with DSF/Cu complex had the greater efficacy in tumor growth inhibition compared with DDP groups whether in LGR5-positive or LGR5-negative cervical cancer cells in vivo. The gene discussed is LGR5; the disease is cervical cancer.